Highlights
1 patentProfile claimed by owner
About
Needle-free Drug Delivery System for the Urinary Bladder
Vensica is developing ViXe, a product that combines Xeomin, a commercial neurotoxin, and Vibe, a breakthrough, needle-free, ultrasound drug delivery device.
Vibe is a breakthrough platform designed to deliver drugs directly into the bladder wall, providing uniform, controlled and localized treatments for urology applications. Vibe leverages a disruptive ultrasound technology to deliver drugs through the natural barriers of the urinary bladder. By generating cavitation bubbles, Vibe precisely microinjects the drugs into the bladder wall, ensuring a controlled and uniform delivery of medications and biologics.
Identity
| Name | Vensica Medical |
|---|---|
| Slug | vensica-medical |
| Type / kind | startup |
| Crunchbase ID | vensica-medical |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6q2vAKDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Netanya |
| HQ address | HaGavish Street 4, Netanya, Israel |
Web & social
| Website | https://vensica.com |
|---|---|
| https://www.linkedin.com/company/5350087 | |
| YouTube | https://www.youtube.com/@VensicaMedical |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Simulation & ImagingUltrasound
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
hospitalscancerdrug-deliverymedical-devicesurinary-systemcathetersultrasoundoncologyurologyminimally-invasivepain-freetreatmentsbioconvergence
Funding
| Total raised | $33.2M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}